Bloomberg Quicktake: Now published this video item, entitled “FDA Panel Rejects Pfizer Booster Plan, Mulls Narrower One” – below is their description.
A U.S. Food and Drug Administration panel of expert advisers voted against a third dose of the Pfizer Inc.-BioNTech SE vaccine for everyone 16 and older but was considering a booster shot for a more limited population of older adults and other vulnerable populations.
The FDA had asked the advisory panel to vote on whether the safety and effectiveness data submitted by the companies support approval of a booster dose for people age 16 and up.Bloomberg Quicktake: Now YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.